UP!

VNDA $10.3

VNDA target price
10.30
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-11-01 Future report Set alerts
Q2 2022 2022-08-03 0.05 0.05
Q1 2022 2022-05-05 -0.11 -0.11
Q4 2021 2022-02-23 0.00 0.00
Q3 2021 2021-11-03 0.14 0.14
Q2 2021 2021-07-28 0.17 0.17
Q1 2021 2021-05-05 0.15 0.15
Q4 2020 2021-02-10 0.15 0.15
Q3 2020 2020-10-28 0.11 0.11
Q2 2020 2020-08-05 0.16 0.16

Ratings

2016-06-10 Reiterated Rating Jefferies Group Buy
2016-06-06 Reiterated Rating Brean Capital Buy
2016-05-29 Reiterated Rating Jefferies Group Buy
2016-05-27 Reiterated Rating Brean Capital Buy $20.00
2016-05-07 Reiterated Rating Jefferies Group Buy $15.00
2016-04-27 Reiterated Rating Brean Capital Buy $20.00
2016-03-14 Reiterated Rating Canaccord Genuity Buy $18.00
2016-03-09 Lower Price Target JMP Securities Market Outperform $30.00 to $18.00
2016-02-12 Reiterated Rating Canaccord Genuity Buy $18.00
2016-02-10 Reiterated Rating Piper Jaffray Buy
2016-02-10 Reiterated Rating Piper Jaffray Cos. Buy
2016-02-07 Reiterated Rating Brean Capital Buy $20.00
2016-01-06 Reiterated Rating Piper Jaffray Overweight $16.00
2015-12-18 Reiterated Rating Brean Capital Buy $20.00
2015-12-03 Reiterated Rating Piper Jaffray Overweight $16.00
2015-11-04 Reiterated Rating Brean Capital Buy $20.00
2015-11-04 Lower Price Target Jefferies Group Buy $20.00 to $15.00
2015-10-21 Initiated Coverage Brean Capital Buy $20.00
2015-09-24 Reiterated Rating Canaccord Genuity Buy $18.00
2015-09-02 Reiterated Rating Piper Jaffray Buy $16.00
2015-07-30 Reiterated Rating Canaccord Genuity Buy $18.00
2015-07-30 Reiterated Rating Piper Jaffray Overweight $16.00
2015-06-03 Reiterated Rating Canaccord Genuity Buy $18.00
2015-05-07 Reiterated Rating Canaccord Genuity Buy $22.00 to $18.00
2015-05-06 Set Price Target Piper Jaffray Buy $15.00
2015-03-09 Initiated Coverage Jefferies Group Buy $20.00
2015-03-09 Reiterated Rating Piper Jaffray Overweight $18.00
2015-02-22 Reiterated Rating Piper Jaffray Overweight $18.00
2015-02-20 Lower Price Target Jefferies Group Market Outperform $33.00 to $30.00
2015-01-09 Initiated Coverage Canaccord Genuity Buy $22.00
2014-12-24 Set Price Target Piper Jaffray Buy $25.00
2013-11-26 Initiated Coverage Piper Jaffray Overweight $21.00
2013-11-15 Boost Price Target Jefferies Group Buy $13.00 to $20.00
2013-11-15 Set Price Target JMP Securities Market Outperform $19.00 to $23.00
2013-10-21 Reiterated Rating Lazard Capital Markets Buy $22.00
2010-03-10 Initiated Hapoalim Outperform $23
2009-12-09 Initiated Jefferies & Co Buy $22
2008-07-29 Downgrade Banc of America Sec Buy to Neutral
2008-07-28 Downgrade Caris & Company Buy to Above Average $22 to $3
2008-05-02 Initiated Caris & Company Buy $22
2007-09-10 Initiated Banc of America Sec Buy
2007-05-08 Initiated Citigroup Hold
2007-05-01 Reiterated Friedman Billings Outperform $40 to $37
2007-02-14 Initiated Friedman Billings Outperform $40
2016-06-10 Reiterated Rating Jefferies Group Buy
2016-06-06 Reiterated Rating Brean Capital Buy
2016-05-29 Reiterated Rating Jefferies Group Buy
2016-05-27 Reiterated Rating Brean Capital Buy $20.00
2016-05-07 Reiterated Rating Jefferies Group Buy $15.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
TANG KEVIN C 8.02%  (2715852) ARDM / CYCC / HRTX / LJPC / ODT / VNDA /
Polymeropoulos Mihael Hristos Chief Executive Officer 3.49%  (1182872) VNDA /
Flynn James E Possible Member of 10% Group 3.26%  (1103617) AAVL / ALIM / ASPX / ATRS / AUXL / AXGN / CASM / CYCC / DRNA / EHTH / EMAG / FIXX / HITK / LOXO / NURO / PRTO / REPH / RIGL / STRM / TRGT / TWTI / VNDA / XNPT /
Kelly James Patrick SVP, CFO, Sec & Treasurer 0.59%  (199534) VNDA /
Clark William D Sr. VP, Chief Business Officer 0.50%  (168279) GNCA / VNDA /
Reverberi Gian Piero SVP, General Manager Europe 0.41%  (140000) VNDA /
Birznieks Gunther SVP, Business Development 0.41%  (139841) VNDA /
Gulino Richard L. SVP & General Counsel 0.34%  (115073) VNDA /
Baroldi Paolo SVP & Chief Medical Officer 0.16%  (54365) VNDA /
DUGAN RICHARD W 0.08%  (25770) VNDA /
Watkins Thomas 0.06%  (20000) HZNP / VNDA /
Repella Robert SVP & Chief Commercial Officer 0.04%  (15000) VNDA /
Feeney John Joseph Acting Chief Medical Officer 0.04%  (11942) VNDA /
Halak Brian K 0.02%  (7276) ACHN / AKAO / ALIM / CADX / CLVS / DRNA / DRTX / ESPR / EVOK / OCRX / OREX / TNDM / VCYT / VNDA / ZGNX /
COLA MICHAEL F 0.01%  (5000) MDGN / PATH / SAGE / VNDA /
MILANO VINCENT 0.01%  (5000) IDRA / VNDA / VPHM /
BATE KENNETH 0.01%  (5000) AVEO / BMRN / CBST / EPZM / GNCA / SNTA / VNDA /
Irish Stephanie Rast Acting CFO/Treasurer 0.01%  (2249) VNDA /